These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33575471)

  • 21. PIM1 kinase promotes gallbladder cancer cell proliferation via inhibition of proline-rich Akt substrate of 40 kDa (PRAS40).
    Subbannayya T; Leal-Rojas P; Zhavoronkov A; Ozerov IV; Korzinkin M; Babu N; Radhakrishnan A; Chavan S; Raja R; Pinto SM; Patil AH; Barbhuiya MA; Kumar P; Guerrero-Preston R; Navani S; Tiwari PK; Kumar RV; Prasad TSK; Roa JC; Pandey A; Sidransky D; Gowda H; Izumchenko E; Chatterjee A
    J Cell Commun Signal; 2019 Jun; 13(2):163-177. PubMed ID: 30666556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing.
    Li M; Chen L; Qu Y; Sui F; Yang Q; Ji M; Shi B; Chen M; Hou P
    Oncotarget; 2017 May; 8(22):36319-36330. PubMed ID: 28422736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.
    Weber H; Valbuena JR; Barbhuiya MA; Stein S; Kunkel H; García P; Bizama C; Riquelme I; Espinoza JA; Kurtz SE; Tyner JW; Calderon JF; Corvalán AH; Grez M; Pandey A; Leal-Rojas P; Roa JC
    Oncotarget; 2017 Apr; 8(16):26169-26184. PubMed ID: 28412732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment and characterization of patient-derived primary cell lines as preclinical models for gallbladder carcinoma.
    Feng F; Huang C; Xiao M; Wang H; Gao Q; Chen Z; Xu X; Zhou J; Li F; Li Y; Zhang D; Chang Y; Jiang X
    Transl Cancer Res; 2020 Mar; 9(3):1698-1710. PubMed ID: 35117518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway.
    Li M; Zhang Z; Li X; Ye J; Wu X; Tan Z; Liu C; Shen B; Wang XA; Wu W; Zhou D; Zhang D; Wang T; Liu B; Qu K; Ding Q; Weng H; Ding Q; Mu J; Shu Y; Bao R; Cao Y; Chen P; Liu T; Jiang L; Hu Y; Dong P; Gu J; Lu W; Shi W; Lu J; Gong W; Tang Z; Zhang Y; Wang X; Chin YE; Weng X; Zhang H; Tang W; Zheng Y; He L; Wang H; Liu Y; Liu Y
    Nat Genet; 2014 Aug; 46(8):872-6. PubMed ID: 24997986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.
    Bao RF; Shu YJ; Hu YP; Wang XA; Zhang F; Liang HB; Ye YY; Li HF; Xiang SS; Weng H; Cao Y; Wu XS; Li ML; Wu WG; Zhang YJ; Jiang L; Dong Q; Liu YB
    Oncotarget; 2016 Apr; 7(16):22339-54. PubMed ID: 26968949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MYBL2 is a Potential Prognostic Marker that Promotes Cell Proliferation in Gallbladder Cancer.
    Liang HB; Cao Y; Ma Q; Shu YJ; Wang Z; Zhang F; Ye YY; Li HF; Xiang SS; Song XL; Xu Y; Zhang YC; Bao RF; Yuan RY; Zhang YJ; Hu YP; Jiang L; Li ML; Wang XA; Wu XS; Wu WG; Zhao S; Fand Y; Cui XP; Lu YS; Zhou J; Zheng L; Gong W; Liu YB
    Cell Physiol Biochem; 2017; 41(5):2117-2131. PubMed ID: 28427077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
    Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel biomarkers for the diagnosis and prognosis of gallbladder cancer.
    Lin HZ; Zhang T; Chen MY; Shen JL
    J Dig Dis; 2021 Feb; 22(2):62-71. PubMed ID: 33369216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer.
    Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
    Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway.
    Zhang F; Li M; Wu X; Hu Y; Cao Y; Wang X; Xiang S; Li H; Jiang L; Tan Z; Lu W; Weng H; Shu Y; Gong W; Wang X; Zhang Y; Shi W; Dong P; Gu J; Liu Y
    Drug Des Devel Ther; 2015; 9():3969-87. PubMed ID: 26309394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.
    Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ
    Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.
    Chen J; Yu Y; Chen X; He Y; Hu Q; Li H; Han Q; Ren F; Li J; Li C; Bao J; Ren Z; Duan Z; Cui G; Sun R
    Cell Prolif; 2018 Dec; 51(6):e12510. PubMed ID: 30105813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LDHA is a direct target of miR-30d-5p and contributes to aggressive progression of gallbladder carcinoma.
    He Y; Chen X; Yu Y; Li J; Hu Q; Xue C; Chen J; Shen S; Luo Y; Ren F; Li C; Bao J; Yan J; Qian G; Ren Z; Sun R; Cui G
    Mol Carcinog; 2018 Jun; 57(6):772-783. PubMed ID: 29569755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11/STAT3 signaling pathway.
    Yang L; Gao Q; Wu X; Feng F; Xu K
    J Exp Clin Cancer Res; 2018 Aug; 37(1):186. PubMed ID: 30086773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desulfation of cell surface HSPG is an effective strategy for the treatment of gallbladder carcinoma.
    Yi B; Qiu Y; Ji W; Wei M; Liu C; Peng Z; Zhang Y; Quan Z; Tang Z; Su C
    Cancer Lett; 2016 Oct; 381(2):349-58. PubMed ID: 27502167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway.
    Wu XS; Wang XA; Wu WG; Hu YP; Li ML; Ding Q; Weng H; Shu YJ; Liu TY; Jiang L; Cao Y; Bao RF; Mu JS; Tan ZJ; Tao F; Liu YB
    Cancer Biol Ther; 2014 Jun; 15(6):806-14. PubMed ID: 24658096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and functional characterization of INPP4B in gallbladder cancer patients and gallbladder cancer cells.
    Wu Y; Meng D; Xu X; Bao J; You Y; Sun Y; Li Y; Sun D
    BMC Cancer; 2021 Apr; 21(1):433. PubMed ID: 33879096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of mTOR pathway attenuates migration and invasion of gallbladder cancer via EMT inhibition.
    Zong H; Yin B; Zhou H; Cai D; Ma B; Xiang Y
    Mol Biol Rep; 2014 Jul; 41(7):4507-12. PubMed ID: 24623408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo.
    Qin Y; Zhou Y; Ge A; Chang L; Shi H; Fu Y; Luo Q
    Biomed Pharmacother; 2019 Oct; 118():109266. PubMed ID: 31401397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.